[HTML][HTML] Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later
W Tao, X Yang, Q Zhang, S Bi, Z Yao - Frontiers in Cardiovascular …, 2023 - frontiersin.org
Background: Dapagliflozin (DAPA) and sacubitril-valsartan (S/V) can improve the prognosis
of patients with heart failure (HF). We tested whether early initiation of SGLT2i, or different …
of patients with heart failure (HF). We tested whether early initiation of SGLT2i, or different …
Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later
W Tao, X Yang, Q Zhang, S Bi… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Based on previous research, both dapagliflozin (DAPA) and sacubitril-valsartan
(S/V) improve the prognosis of patients with heart failure (HF). Our study aims to investigate …
(S/V) improve the prognosis of patients with heart failure (HF). Our study aims to investigate …
[HTML][HTML] Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later
W Tao, X Yang, Q Zhang, S Bi, Z Yao - Frontiers in Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Background Based on previous research, both dapagliflozin (DAPA) and sacubitril-valsartan
(S/V) improve the prognosis of patients with heart failure (HF). Our study aims to investigate …
(S/V) improve the prognosis of patients with heart failure (HF). Our study aims to investigate …
[引用][C] Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later
W Tao, X Yang, Q Zhang, S Bi, Z Yao - 2023 - europepmc.org
Background: Based on previous research, both dapagliflozin (DAPA) and sacubitril-
valsartan (S/V) improve the prognosis of patients with heart failure (HF). Our study aims to …
valsartan (S/V) improve the prognosis of patients with heart failure (HF). Our study aims to …